131 related articles for article (PubMed ID: 18552379)
1. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
2. Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Sipos E; Hegyi K; Treszl A; Steiber Z; Mehes G; Dobos N; Fodor K; Olah G; Szekvolgyi L; Schally AV; Halmos G
Oncol Rep; 2017 Apr; 37(4):1927-1934. PubMed ID: 28350068
[TBL] [Abstract][Full Text] [Related]
3. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
Cai L; Paez-Escamilla M; Walter SD; Tarlan B; Decatur CL; Perez BM; Harbour JW
Am J Ophthalmol; 2018 Nov; 195():154-160. PubMed ID: 30092184
[TBL] [Abstract][Full Text] [Related]
5. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
Liu Z; Yu L; Lai J; Zhang R
Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
[TBL] [Abstract][Full Text] [Related]
6. Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.
Singh AD; Aronow ME; Sun Y; Bebek G; Saunthararajah Y; Schoenfield LR; Biscotti CV; Tubbs RR; Triozzi PL; Eng C
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3331-9. PubMed ID: 22511634
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.
Miguez S; Lee RY; Chan AX; Demkowicz PC; Jones BSCL; Long CP; Abramson DH; Bosenberg M; Sznol M; Kluger H; Goldbaum MH; Francis JH; Pointdujour-Lim R; Bakhoum MF
Ophthalmology; 2023 Jun; 130(6):598-607. PubMed ID: 36739981
[TBL] [Abstract][Full Text] [Related]
9. Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers.
Velez G; Wolf J; Dufour A; Mruthyunjaya P; Mahajan VB
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):14. PubMed ID: 37955612
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning Methods for Gene Selection in Uveal Melanoma.
Reggiani F; El Rashed Z; Petito M; Pfeffer M; Morabito A; Tanda ET; Spagnolo F; Croce M; Pfeffer U; Amaro A
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339073
[TBL] [Abstract][Full Text] [Related]
11. Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis.
Gallenga CE; Franco E; Adamo GG; Violanti SS; Tassinari P; Tognon M; Perri P
Front Oncol; 2022; 12():828112. PubMed ID: 35480119
[TBL] [Abstract][Full Text] [Related]
12. Identification of three master regulatory genes with prognostic value for uveal melanoma by means of weighted co-expression network analysis.
Diaz MJ; Tran JT; Montanez-Wiscovich M
Skin Res Technol; 2023 Jul; 29(7):e13358. PubMed ID: 37522506
[No Abstract] [Full Text] [Related]
13. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder.
Phillips ML; Ladouceur CD; Drevets WC
Mol Psychiatry; 2008 Sep; 13(9):829, 833-57. PubMed ID: 18574483
[TBL] [Abstract][Full Text] [Related]
14. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.
Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
Joensuu H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Ramadori G; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Nilsson B; Sihto H; Bono P; Kallio R; Junnila J; Alvegård T; Reichardt P
J Clin Oncol; 2016 Jan; 34(3):244-50. PubMed ID: 26527782
[TBL] [Abstract][Full Text] [Related]
16. The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration.
Logue MW; Amstadter AB; Baker DG; Duncan L; Koenen KC; Liberzon I; Miller MW; Morey RA; Nievergelt CM; Ressler KJ; Smith AK; Smoller JW; Stein MB; Sumner JA; Uddin M
Neuropsychopharmacology; 2015 Sep; 40(10):2287-97. PubMed ID: 25904361
[TBL] [Abstract][Full Text] [Related]
17. Age-related macular degeneration: prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011.
Park SJ; Lee JH; Woo SJ; Ahn J; Shin JP; Song SJ; Kang SW; Park KH;
Ophthalmology; 2014 Sep; 121(9):1756-65. PubMed ID: 24813632
[TBL] [Abstract][Full Text] [Related]
18. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Corless CL; Ballman KV; Antonescu CR; Kolesnikova V; Maki RG; Pisters PW; Blackstein ME; Blanke CD; Demetri GD; Heinrich MC; von Mehren M; Patel S; McCarter MD; Owzar K; DeMatteo RP
J Clin Oncol; 2014 May; 32(15):1563-70. PubMed ID: 24638003
[TBL] [Abstract][Full Text] [Related]
19. The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis.
Boichuk S; Parry JA; Makielski KR; Litovchick L; Baron JL; Zewe JP; Wozniak A; Mehalek KR; Korzeniewski N; Seneviratne DS; Schöffski P; Debiec-Rychter M; DeCaprio JA; Duensing A
Cancer Res; 2013 Aug; 73(16):5120-9. PubMed ID: 23786773
[TBL] [Abstract][Full Text] [Related]
20. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial.
Than M; Cullen L; Aldous S; Parsonage WA; Reid CM; Greenslade J; Flaws D; Hammett CJ; Beam DM; Ardagh MW; Troughton R; Brown AF; George P; Florkowski CM; Kline JA; Peacock WF; Maisel AS; Lim SH; Lamanna A; Richards AM
J Am Coll Cardiol; 2012 Jun; 59(23):2091-8. PubMed ID: 22578923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
